Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1975 Aug;2(4):321–325. doi: 10.1111/j.1365-2125.1975.tb02778.x

Measurement of plasma prednisolone in man.

C G Wilson, R Ssendagire, C S May, J W Paterson
PMCID: PMC1402599  PMID: 1233991

Abstract

1. A modification of the competitive protein binding assay for prednisolone described by English, Chakraborty & Marks (1974) is presented. 2. Addition of pg quantities of [3H]-prednisolone following oral dosage with prednisone or prednisolone. 3. Mean plasma half-life and peak plasma concentrations in patients with respiratory disease seen following prednisolone administration agree well with previous studies in healthy volunteers performed by other workers using competitive protein binding and radioimmunoassay techniques. 4. A considerable inter-patient variation in bioavailability after a standard dose of prednisolone (20 mg) was noted.

Full text

PDF
321

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Colburn W. A., Buller R. H. Radioimmunoassay for prednisolone. Steroids. 1973 Jun;21(6):833–846. doi: 10.1016/0039-128x(73)90124-4. [DOI] [PubMed] [Google Scholar]
  2. D'Arcy P. F., Griffin J. P., Jenkins J. S., Kirk W. F., Peacock A. W. Sustained-release formulation of prednisolone administered orally to man. J Pharm Sci. 1971 Jul;60(7):1028–1033. doi: 10.1002/jps.2600600705. [DOI] [PubMed] [Google Scholar]
  3. Jenkins J. S., Sampson P. A. Conversion of cortisone to cortisol and prednisone to prednisolone. Br Med J. 1967 Apr 22;2(5546):205–207. doi: 10.1136/bmj.2.5546.205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Koch-Weser J. Drug therapy. Serum drug concentrations as therapeutic guides. N Engl J Med. 1972 Aug 3;287(5):227–231. doi: 10.1056/NEJM197208032870505. [DOI] [PubMed] [Google Scholar]
  5. Pegg P. J., Keane P. M. The simultaneous estimation of plasma cortisol and transcortin binding characteristics by a competitive protein binding technique. Steroids. 1969 Dec;14(6):705–715. doi: 10.1016/s0039-128x(69)80077-2. [DOI] [PubMed] [Google Scholar]
  6. Sandberg D. H., Bacallao C. Z., Cleveland W. W. Measurement of plasma prednisolone by a competitive protein-binding assay. Biochem Med. 1970 Dec;4(5):383–390. doi: 10.1016/0006-2944(70)90066-9. [DOI] [PubMed] [Google Scholar]
  7. Vessell E. S., Passananti G. T. Utility of clinical chemical determinations of drug concentrations in biological fluids. Clin Chem. 1971 Sep;17(9):851–866. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES